Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2.

Blood - 1 Mar 2004

Urosevic Mirjana, Kamarashev Jivko, Burg Günter, Dummer Reinhard

Abstract excerpt

Primary cutaneous lymphomas constitute a spectrum of diseases characterized by a clonal accumulation of lymphocytes in the skin. Cutaneous T-cell lymphomas of the cytotoxic phenotype, including CD8+ and CD56+ lymphomas, are rare entities that have only been recently recognized and characterized. These lymphomas often show an aggressive clinical course. We investigated the expression of human leukocyte antigen G...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD56 Antigen
Share to CD8 Antigens
Share to HLA-G Antigens

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Interleukin-10

Share to Killer Cells, Natural

Share to Lymphoma

Share to Lymphoma, T-Cell

Share to Receptors, Immunologic

Source

Identifiers

PMID: 14592815
DOI: 10.1182/blood-2003-10-3372

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2.PMID 14592815Read ↗

Dermatologic Perspectives on Primary Cutaneous Lymphomas: Clinicopathologic Spectrum, Molecular Insights and Evolving Treatment ParadigmsSemantic proximity Read ↗

Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.Semantic proximity Read ↗

Cutaneous Lymphomas with Cytotoxic Phenotype.Semantic proximity Read ↗

The Role of HLA-G in Tumor Escape: Manipulating the Phenotype and Function of Immune CellsSemantic proximity Read ↗

Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathwaysSemantic proximity Read ↗

The Role of Cytokines in Cutaneous T-cell Lymphoma: Focus on the State of the Art and Possible Therapeutic TargetsSemantic proximity Read ↗

HLA-G and IL-10 expression in human cancer--different stories with the same message.Semantic proximity Read ↗

Cutaneous LymphomasSemantic proximity Read ↗

A case report: CD8 + aggressive cutaneous epidermotropic T cell lymphoma (ACLAE), a rare and ill-defined subtypeSemantic proximity Read ↗

Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.Semantic proximity Read ↗

Genome-Wide Analysis of Cutaneous T-Cell Lymphomas Identifies Three Clinically Relevant ClassesSemantic proximity Read ↗

Primary cutaneous CD4/CD8-/- TCRαβ T-cell lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.